Potsdam (ots) - Nun ist es amtlich: Der erste Brandenburger darf per Gerichtsbeschluss wegen der Dieselaffäre ...
Jacobs University and Fraunhofer IME signed MoU
Jacobs University Bremen and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME, today (June 11th, 2018) announce their intention to set up a new strategic collaboration to establish joint research projects in the area of antibiotic drug discovery and promote the exchange of students, researchers and educators between the institutions.
Through this partnership, Fraunhofer IME will offer Jacobs University undergraduate students the opportunity to be actively involved in Fraunhofer IME's scientific research agenda, either by enrolling in an internship program or by completing a research project as part of their Bachelor thesis studies. Active involvement of undergraduates in ongoing interdisciplinary research projects at Fraunhofer IME will support the scientific education of the students, and help them to establish future careers in the pharmaceutical and biotechnology industries.
The Fraunhofer IME offers internships in a wide range of experimental and computational disciplines within the economically important Life Science sector, with a focus on drug discovery and development. Doctoral students working at Fraunhofer IME in Hamburg will also be enrolled in PhD programs of Jacobs University.
As part of the collaboration, Fraunhofer IME will share its know-how in applied research and modern drug discovery methods. Experienced scientists from Fraunhofer IME in Hamburg will offer courses, lectures and seminars at Jacobs University, in particular as an integral part of the undergraduate Bachelors program, Medicinal Chemistry and Chemical Biology.
Fraunhofer IME and Jacobs University also intend to exchange scientific staff, in order to share the complementary expertise existing at both institutions. In future, both partners envisage jointly recruiting scientists for shared positions, to help efficiently advance common research projects, particularly those focused on discovering the next generation of treatments against bacterial infections. The potent strategic collaboration will build upon a pre-existing 5-year record of cooperation involving Jacobs and the Fraunhofer IME, which has already attracted substantial funding under the European Union framework programs.
Prof. Werner Nau, Dean of Jacobs University Bremen: "The strategic partnership with the Fraunhofer IME will strengthen our teaching and research in the area Health with a focus on bioactive substances. Our students will get the opportunity to participate in challenging projects which are of prime interest to the pharmaceutical industry."
Dr. Björn Windshügel, Head of Structure-based drug design at Fraunhofer IME: "We are very excited about this collaboration as it will not only advance antibacterial drug discovery research in Northern Germany but also offers various opportunities for joint education of students".
Questions will be answered by:
Prof. Dr. Werner Nau | Jacobs University Bremen
email@example.com| Tel.: +49 421 200-4339
Dr. Björn Windshügel | Fraunhofer IME
firstname.lastname@example.org | Tel.: +49 40 303764-286
About the Fraunhofer Institute for Molecular Biology and Applied Ecology IME:
The Fraunhofer IME conducts research in the field of applied life sciences from a molecular level to entire ecosystems. Our interdisciplinary organization and laboratories with state-of-the-art equipment including GMP facilities and complex facilities for environmental simulations, allow a wide spectrum of research and development services in the divisions ?Molecular Biotechnology?, ?Applied Ecology and Bioresources? and ?Translational Medicine?. The strength of Fraunhofer IME lies in this broad spectrum of scientific and methodological expertise, enabling us to develop innovative and comprehensive solutions to the enormous challenges confronting society in areas such as sustainable agriculture, health and the bio economy. The institute has around 520 employees working at the locations Schmallenberg, Aachen, Münster, Gießen, Frankfurt/Main and Hamburg. Since 2014, Branch Lab ScreeningPort in Hamburg extends the expertise of the Fraunhofer IME in the field of "Translational Medicine" including drug discovery, biomarker identification and bioinformatics.
For more information: www.ime.fraunhofer.de/en/ScreeningPort.html
About Jacobs University Bremen:
Studying in an international community. Obtaining a qualification to work on responsible tasks in a digitized and globalized society. Learning, researching and teaching across academic disciplines and countries. Strengthening people and markets with innovative solutions and advanced training programs. This is what Jacobs University Bremen stands for. Established as a private, English-medium campus university in Germany, it is continuously achieving top results in national and international university rankings. Its almost 1,400 students come from more than 100 countries with around 80% having relocated to Germany for their studies. Jacobs University's research projects are funded by the German Research Foundation or the European Research Council as well as by globally leading companies.
For more information: www.jacobs-university.de
Thomas Joppig | Corporate Communications & Public Relations Jacobs University Bremen gGmbH Campus Ring 1 | 28759 Bremen | Germany Phone: +49 421 200 4504 | Fax +49 421 200 494504 email@example.com www.jacobs-university.de Commercial registry: Amtsgericht Bremen, HRB 18117 President/ Managing Director: Prof. Dr. Michael Hülsmann (Geschäftsführer) Chair Board of Governors: Prof. E. Jürgen Zöllner (Aufsichtsratsvorsitzender)